Emcure Pharmaceuticals (EMCURE) Share Price Falls 2.57% as Large Cap Stock Trades at Rs 1,909.25
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Emcure Pharmaceuticals Share Price is trading at Rs 1,909.25, down 2.57% from the previous close, while the company’s market capitalisation stands at Rs 36,533.53 Cr. The move places Emcure Pharmaceuticals in focus as a large cap healthcare name in today’s market update. Univest data confirms the move itself, though no company-specific trigger has been identified. Emcure Pharmaceuticals Share Price Today therefore reflects an observed decline, not a stated change in business outlook. For readers tracking Emcure Pharmaceuticals Stock News, the key question is what the price data shows and how the fundamentals compare with peers in Pharmaceuticals & Drugs. Univest data also shows that the stock is trading in a range that merits a closer look at valuation, return ratios and sector positioning.
Emcure Pharmaceuticals (EMCURE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,909.25 |
| Previous Close | Rs 1,959.7 |
| Today's Move | -Rs 50.45 (-2.57%) |
| Open | Rs 1,960.05 |
| High | Rs 1,963.7 |
| Low | Rs 1,909 |
| Market Capitalisation | Rs 36,533.53 crore |
| Market Cap Category | Large Cap |
Emcure Pharmaceuticals Share Price Today opened at Rs 1,960.05, touched a high of Rs 1,963.70 and a low of Rs 1,909.00 before last trading at Rs 1,909.25. That leaves the stock Rs 50.45 below the previous close of Rs 1,959.70, marking a 2.57% decline in the latest session. Emcure Pharmaceuticals Share Price is also sitting very near the day’s low, which makes the intraday range important context for the move. With a market capitalisation of Rs 36,533.53 Cr and a Large Cap tag, Emcure Pharmaceuticals Share Price Today remains a meaningful market event for healthcare watchers. According to latest Univest figures, the price action is confirmed, but no company-specific catalyst is established. That keeps the focus on the stock’s price behaviour and the next layer of Emcure Pharmaceuticals Share Price analysis.
For investors following Emcure Pharmaceuticals Share Price Live, the key observation is simple: the stock moved lower from the opening level and stayed weak through the range. Emcure Pharmaceuticals Share Price News therefore centres on the session’s verified price action rather than any external trigger. The next step is to place this Emcure Pharmaceuticals Share Price move against fundamentals.
Emcure Pharmaceuticals (EMCURE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 36,533.53 crore |
| P/E Ratio | 36.76x |
| P/B Ratio | 7.11x |
| ROE | 20.09% |
| ROCE | 25.25% |
| EPS | Rs 53.31 |
| Book Value Per Share | Rs 275.72 |
| Dividend Yield | 0.18% |
Emcure Pharmaceuticals Share Price is supported by a market capitalisation of Rs 36,533.53 Cr, an enterprise value that investors often compare with profitability and return ratios. The stock trades at a P/E ratio of 36.76 and a P/B ratio of 7.11, which places Emcure Pharmaceuticals Share Price in a valuation zone that needs to be read alongside growth and return metrics rather than in isolation. EPS stands at Rs 53.31, showing the earnings attributable to each share, while book value is Rs 275.72 per share. Dividend yield is 0.18%, which is a modest cash-return indicator at the current Emcure Pharmaceuticals Share Price.
Return metrics add more context. ROE is 20.09% and ROCE is 25.25%, both useful signs when investors review Emcure Pharmaceuticals Fundamental Analysis. These figures show that the stock is not just about price movement; Emcure Pharmaceuticals Share Price also reflects a business that is generating returns above many sector norms. The combination of a higher P/B ratio with strong ROE and ROCE gives Emcure Pharmaceuticals Share Price a valuation profile that deserves comparison with peers and the industry benchmark. For readers tracking Emcure Pharmaceuticals Stock Analysis, the central takeaway is that the fall in Emcure Pharmaceuticals Share Price Today is happening against a backdrop of solid return ratios rather than weak returns. Univest data keeps the emphasis on measured interpretation, not prediction.
In practical terms, Emcure Pharmaceuticals Share Price News today is less about a broken thesis and more about a visible price dip against a well-defined financial base. That makes the next sector comparison especially relevant for Emcure Pharmaceuticals Share Price.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 36.76x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 7.11x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 20.09% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 25.25% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 36,533.53 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Emcure Pharmaceuticals Share Price sits inside the Healthcare sector and the Pharmaceuticals & Drugs industry, where the same-industry benchmark covers 199 companies. Against that benchmark, Emcure Pharmaceuticals Share Price trades at a P/E of 36.76 versus a median of 32.43 and an average of 49.46. Its P/B ratio of 7.11 is above the benchmark median of 2.89 and the average of 4.38. ROE at 20.09% is above the benchmark median of 11.7% and average of 10.68%, while ROCE at 25.25% is also above the median of 13.61% and average of 13.4%.
The benchmark scope matters because it gives Emcure Pharmaceuticals Share Price Today a clear frame of reference. Among the same-industry set, company count, valuation distribution and return metrics vary widely, and Emcure Pharmaceuticals Share Price is positioned above the benchmark centre on both P/E and P/B. The market capitalisation benchmark median is Rs 776.09 Cr, the average is Rs 14,255.4 Cr, and the industry spans from Rs 6.06 Cr to Rs 4,41,477.63 Cr. Emcure Pharmaceuticals Share Price therefore sits in a much larger company bucket than the median industry name. In sector terms, the stock’s return ratios are stronger than the benchmark centre, even as its valuation remains above the median. That is the key sector analysis for readers comparing Emcure Pharmaceuticals Share Price with the broader healthcare set.
For Emcure Pharmaceuticals Stock News, this industry context is important because it shows the stock’s place within a broad pharmaceutical universe rather than as an isolated intraday move. Univest data points to a valuation that is richer than the industry median but backed by stronger return ratios than the benchmark centre.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,477.63 | 36.9 | 5.16 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,031.38 | 85.99 | 14.24 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
Emcure Pharmaceuticals Share Price can be read more clearly beside listed peers such as Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla Among these, Emcure Pharmaceuticals Share Price at a P/E of 36.76 is close to Sun Pharmaceutical Industries at 36.9 and above Zydus Lifesciences at 26.42 and Cipla at 33.15. It is well below Divi’s Laboratories at 85.99 and Torrent Pharmaceuticals at 85.72.
On return ratios, Emcure Pharmaceuticals Share Price shows ROE of 20.09% and ROCE of 25.25%, which are stronger than Sun Pharmaceutical Industries and Cipla, while remaining below Lupin on both measures in the wider comparison set. Market capitalisation also shows how large the leading names are: Emcure Pharmaceuticals Share Price is much smaller than Sun Pharmaceutical Industries and Divi’s Laboratories, but larger than several peer group names in the selected set. That makes Emcure Pharmaceuticals Share Price a mid-tier large cap within a strong healthcare basket, with valuation and return ratios that compare favourably to several listed peers. For Emcure Pharmaceuticals Stock Analysis, the peer lens suggests the stock is neither the lowest-valued nor the richest, but it does carry stronger profitability ratios than several competitors.
Why Investors Are Watching Emcure Pharmaceuticals
- Emcure Pharmaceuticals Share Price fell 2.57% in the latest session, so intraday price action is the first point to watch.
- The stock trades as a Large Cap name with Rs 36,533.53 Cr market capitalisation, which keeps Emcure Pharmaceuticals Share Price relevant for broad market tracking.
- P/E of 36.76 and P/B of 7.11 place Emcure Pharmaceuticals Share Price above the industry median on valuation.
- ROE of 20.09% and ROCE of 25.25% give Emcure Pharmaceuticals Fundamental Analysis a stronger return profile than the benchmark centre.
- Peers such as Zydus Lifesciences and Cipla help frame Emcure Pharmaceuticals Share Price within Pharmaceuticals & Drugs.
About Emcure Pharmaceuticals
Emcure Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Emcure Pharmaceuticals Share Price is linked to a business that participates in the pharmaceutical market as a large listed company with a market capitalisation of Rs 36,533.53 Cr. The company’s revenue mix, product portfolio and operating details are not part of this price note, so the focus stays on the verified company context and market position. Emcure Pharmaceuticals Share News today therefore centres on the company’s listed status, sector placement and financial ratios rather than a business update. For readers tracking Emcure Pharmaceuticals Stock News, the relevant context is that it is a sizable pharma name with return metrics that remain central to Emcure Pharmaceuticals Share Price discussion.
Track Emcure Pharmaceuticals Share Price on Univest
Use Emcure Pharmaceuticals (EMCURE) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Users can track Emcure Pharmaceuticals Share Price on Univest for live price updates, key ratios, 52-week levels and market insights in one place. Emcure Pharmaceuticals Share Price Today can be monitored alongside fundamental ratios, peer context and sector benchmark readings. Univest also helps readers follow Emcure Pharmaceuticals Stock News and Emcure Pharmaceuticals Share Price Update in a structured, data-first format.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Emcure Pharmaceuticals Share Price falling today?
Ans. Emcure Pharmaceuticals Share Price is down 2.57% today, but according to Univest data, the price event is confirmed, and no company-specific catalyst is established. The move is best read through price action, valuation and peer context.
What is the current Emcure Pharmaceuticals Share Price?
Ans. Emcure Pharmaceuticals Share Price is trading at Rs 1,909.25. It is below the previous close of Rs 1,959.70 and near the day’s low of Rs 1,909.00, which makes today’s decline visible in intraday trading.
How much did Emcure Pharmaceuticals Share Price fall today?
Ans. Emcure Pharmaceuticals Share Price fell by Rs 50.45, or 2.57%, in the latest session. The stock opened at Rs 1,960.05 and moved between Rs 1,963.70 and Rs 1,909.00 during the day.
What is Emcure Pharmaceuticals market capitalisation?
Ans. Emcure Pharmaceuticals has a market capitalisation of Rs 36,533.53 Cr. That places Emcure Pharmaceuticals Share Price in the Large Cap category and well above the same-industry median market capitalisation of Rs 776.09 Cr.
Is Emcure Pharmaceuticals Share Price expensive relative to peers?
Ans. Emcure Pharmaceuticals Share Price trades at 36.76 times earnings and 7.11 times book value. Those levels are above the industry median, but its ROE and ROCE are also above the benchmark centre, which adds context.
What do ROE and ROCE show for Emcure Pharmaceuticals?
Ans. Emcure Pharmaceuticals reports ROE of 20.09% and ROCE of 25.25%. These ratios show how efficiently the business generates returns, and they compare favourably with the benchmark median and average in the industry set.
How does Emcure Pharmaceuticals compare with healthcare peers?
Ans. Emcure Pharmaceuticals Share Price sits close to Sun Pharmaceutical Industries on P/E and above Zydus Lifesciences and Cipla on valuation. Its return ratios are stronger than several peers in the selected comparison.
Should investors track Emcure Pharmaceuticals Share Price on Univest?
Ans. Yes. Emcure Pharmaceuticals Share Price on Univest can be tracked with live price, fundamentals, peer comparison and sector context. That helps readers follow Emcure Pharmaceuticals Stock News and Emcure Pharmaceuticals Share Price Today in one place.
